These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
382 related articles for article (PubMed ID: 28176270)
41. Self-Assembled Nanocarriers Based on Amphiphilic Natural Polymers for Anti- Cancer Drug Delivery Applications. Sabra S; Abdelmoneem M; Abdelwakil M; Mabrouk MT; Anwar D; Mohamed R; Khattab S; Bekhit A; Elkhodairy K; Freag M; Elzoghby A Curr Pharm Des; 2017; 23(35):5213-5229. PubMed ID: 28552068 [TBL] [Abstract][Full Text] [Related]
42. Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer. Saad M; Garbuzenko OB; Minko T Nanomedicine (Lond); 2008 Dec; 3(6):761-76. PubMed ID: 19025451 [TBL] [Abstract][Full Text] [Related]
43. Recent advances in co-delivery systems based on polymeric nanoparticle for cancer treatment. Afsharzadeh M; Hashemi M; Mokhtarzadeh A; Abnous K; Ramezani M Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1095-1110. PubMed ID: 28954547 [TBL] [Abstract][Full Text] [Related]
44. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles. Wu Y; Zhang Y; Zhang W; Sun C; Wu J; Tang J Colloids Surf B Biointerfaces; 2016 Feb; 138():60-9. PubMed ID: 26655793 [TBL] [Abstract][Full Text] [Related]
45. Co-delivery of hypoxia inducible factor-1α small interfering RNA and 5-fluorouracil to overcome drug resistance in gastric cancer SGC-7901 cells. Chen Y; Sun L; Guo D; Wu Z; Chen W J Gene Med; 2017 Dec; 19(12):. PubMed ID: 29106062 [TBL] [Abstract][Full Text] [Related]
46. Multifunctional nanoparticles co-delivering EZH2 siRNA and etoposide for synergistic therapy of orthotopic non-small-cell lung tumor. Yuan ZQ; Chen WL; You BG; Liu Y; Yang SD; Li JZ; Zhu WJ; Zhou XF; Liu C; Zhang XN J Control Release; 2017 Dec; 268():198-211. PubMed ID: 29061511 [TBL] [Abstract][Full Text] [Related]
47. Redox-responsive nanocarriers for drug and gene co-delivery based on chitosan derivatives modified mesoporous silica nanoparticles. Lin JT; Liu ZK; Zhu QL; Rong XH; Liang CL; Wang J; Ma D; Sun J; Wang GH Colloids Surf B Biointerfaces; 2017 Jul; 155():41-50. PubMed ID: 28407530 [TBL] [Abstract][Full Text] [Related]
48. Combinational drug delivery using nanocarriers for breast cancer treatments: A review. Olov N; Bagheri-Khoulenjani S; Mirzadeh H J Biomed Mater Res A; 2018 Aug; 106(8):2272-2283. PubMed ID: 29577607 [TBL] [Abstract][Full Text] [Related]
49. Macroporous silica nanoparticles for delivering Bcl2-function converting peptide to treat multidrug resistant-cancer cells. Xu W; Ge P; Niu B; Zhang X; Liu J; Xie J J Colloid Interface Sci; 2018 Oct; 527():141-150. PubMed ID: 29787950 [TBL] [Abstract][Full Text] [Related]
50. Dendronized Systems for the Delivery of Chemotherapeutics. Dockery L; Daniel MC Adv Cancer Res; 2018; 139():85-120. PubMed ID: 29941108 [TBL] [Abstract][Full Text] [Related]
51. Oral siRNA Delivery to Treat Colorectal Liver Metastases. Kang SH; Revuri V; Lee SJ; Cho S; Park IK; Cho KJ; Bae WK; Lee YK ACS Nano; 2017 Oct; 11(10):10417-10429. PubMed ID: 28902489 [TBL] [Abstract][Full Text] [Related]
52. The Promising Nanocarrier for Doxorubicin and siRNA Co-delivery by PDMAEMA-based Amphiphilic Nanomicelles. Cheng Q; Du L; Meng L; Han S; Wei T; Wang X; Wu Y; Song X; Zhou J; Zheng S; Huang Y; Liang XJ; Cao H; Dong A; Liang Z ACS Appl Mater Interfaces; 2016 Feb; 8(7):4347-56. PubMed ID: 26835788 [TBL] [Abstract][Full Text] [Related]
53. Polymer-Brush-Grafted Mesoporous Silica Nanoparticles for Triggered Drug Delivery. Zhang L; Bei HP; Piao Y; Wang Y; Yang M; Zhao X Chemphyschem; 2018 Aug; 19(16):1956-1964. PubMed ID: 29575338 [TBL] [Abstract][Full Text] [Related]
54. Doxorubicin and siRNA Codelivery via Chitosan-Coated pH-Responsive Mixed Micellar Polyplexes for Enhanced Cancer Therapy in Multidrug-Resistant Tumors. Butt AM; Amin MC; Katas H; Abdul Murad NA; Jamal R; Kesharwani P Mol Pharm; 2016 Dec; 13(12):4179-4190. PubMed ID: 27934479 [TBL] [Abstract][Full Text] [Related]
55. Combinatorial therapeutic approaches with RNAi and anticancer drugs using nanodrug delivery systems. Babu A; Munshi A; Ramesh R Drug Dev Ind Pharm; 2017 Sep; 43(9):1391-1401. PubMed ID: 28523942 [TBL] [Abstract][Full Text] [Related]
56. Combination Nanopreparations of a Novel Proapoptotic Drug - NCL-240, TRAIL and siRNA. Riehle R; Pattni B; Jhaveri A; Kulkarni A; Thakur G; Degterev A; Torchilin V Pharm Res; 2016 Jul; 33(7):1587-601. PubMed ID: 26951567 [TBL] [Abstract][Full Text] [Related]
57. Co-delivery of chemosensitizing siRNA and an anticancer agent via multiple monocomplexation-induced hydrophobic association. Lee E; Oh C; Kim IS; Kwon IC; Kim S J Control Release; 2015 Jul; 210():105-14. PubMed ID: 25979325 [TBL] [Abstract][Full Text] [Related]
58. Cancer-targeted MDR-1 siRNA delivery using self-cross-linked glycol chitosan nanoparticles to overcome drug resistance. Yhee JY; Song S; Lee SJ; Park SG; Kim KS; Kim MG; Son S; Koo H; Kwon IC; Jeong JH; Jeong SY; Kim SH; Kim K J Control Release; 2015 Jan; 198():1-9. PubMed ID: 25481438 [TBL] [Abstract][Full Text] [Related]
59. Tailored Mesoporous Silica Nanoparticles for Controlled Drug Delivery: Platform Fabrication, Targeted Delivery, and Computational Design and Analysis. She X; Chen L; Yi Z; Li C; He C; Feng C; Wang T; Shigdar S; Duan W; Kong L Mini Rev Med Chem; 2018; 18(11):976-989. PubMed ID: 27145854 [TBL] [Abstract][Full Text] [Related]
60. Amphiphilic hyper-branched co-polymer nanoparticles for the controlled delivery of anti-tumor agents. Miao Q; Xu D; Wang Z; Xu L; Wang T; Wu Y; Lovejoy DB; Kalinowski DS; Richardson DR; Nie G; Zhao Y Biomaterials; 2010 Oct; 31(28):7364-75. PubMed ID: 20599267 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]